NexStent launches in Europe
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will distribute EndoTex' carotid stent for use with its Monorail delivery system in Europe, according to April 13 announcements from the firms. EndoTex plans to submit a PMA covering the use of NexStent in conjunction with Boston Scientific's FilterWire embolic protection device this summer, with approval expected in the first quarter of 2006. Boston Scientific has agreed to acquire EndoTex upon the completion of certain regulatory milestones (1"The Gray Sheet" May 26, 2003, p. 26)...
You may also be interested in...
Boston Scientific Extends EndoTex Purchase Option; NexStent Evaluated
EndoTex Interventional Systems is planning an early 2004 launch of its self-expanding NexStent carotid stent outside the U.S., using Boston Scientific as exclusive distributor under an extended agreement between the firms
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.